Publications by authors named "Richard Preston"

Claim this Profile
P
Pharmacokinetics, safety, and tolerability of fedratinib in adults with moderate and severe hepatic impairment: results from the phase 1 FEDR-CP-001 trial.
Yizhe Chen, Richard A Preston, Thomas Marbury, William B Smith, Massimo Attanasio

Cancer Chemother Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Hepatic Impairment on Trilaciclib Pharmacokinetics.
Chao Li, Richard A Preston, Emily Dumas, Andrew Beelen, Thomas C Marbury

J Clin Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Multiple-Dose Alpelisib in Participants with Moderate or Severe Hepatic Impairment: A Phase 1, Open-Label, Parallel Group Study.
Thomas Marbury, Mona El-Hashimy, Lars Blumenstein, Franck Letellier, Tirtha Sengupta, Richard Alfred Preston

J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment.
Sima S Toussi, Joel Michael Neutel, Jesus Navarro, Richard Alfred Preston, Haihong Shi

Clin Pharmacol Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment.
Yan Xu, Raquel Izumi, Helen Nguyen, Anna Kwan, Howard Kuo, Richard A Preston

J Clin Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Potassium-Induced Natriuresis in Hypertensive Postmenopausal Women During Both Low and High Sodium Intake.
Richard A Preston, David Afshartous, Evelyn V Caizapanta, Barry J Materson, Rolando Rodco

Hypertension· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Gepotidacin in Subjects With Normal Hepatic Function and Hepatic Impairment.
Mohammad Hossain, Courtney Tiffany, Yu Tao, Aline Barth, Thomas C Marbury, Richard A Preston

Clin Pharmacol Drug Dev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic Impairment.
Richard A Preston, Thomas Marbury, Ganesh Balaratnam, Michelle Green, Sandy Dixon

J Clin Pharmacol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiazide-Sensitive NCC (Sodium-Chloride Cotransporter) in Human Metabolic Syndrome: Sodium Sensitivity and Potassium-Induced Natriuresis.
Richard A Preston, David Afshartous, Evelyn V Caizapanta, Barry J Materson, Rolando Rodco

Hypertension· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Gepotidacin in Renal Impairment.
Mohammad Hossain, Courtney Tiffany, Aparna Raychaudhuri, Dung Nguyen, Guoying Tai, Richard A Preston

Clin Pharmacol Drug Dev· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment.
Ying C Ou, Richard A Preston, Thomas C Marbury, Zhiyu Tang, William Novotny

Leuk Lymphoma· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Center Investigation of the Pharmacokinetics of WCK 4282 (Cefepime-Tazobactam Combination) in Renal Impairment.
Richard A Preston, Grigor Mamikonyan, Mushtaque Mastim, Dyal Garg, Christopher J Kemper

Antimicrob Agents Chemother· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects.
John O'Donnell, Richard A Preston, Grigor Mamikonyan, Emily Stone, Robin Isaacs

Antimicrob Agents Chemother· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment.
Matthew P Kosloski, Haoyu Wang, David Pugatch, Federico J Mensa, Edward Gane, Richard A Preston

Eur J Clin Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of minority patients with very severe hypertension (>220/>120 mmHg).
Richard A Preston, Rafael Arciniegas, Stephane DeGraff, Barry J Materson, Jeffrey Bernstein

J Hypertens· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment.
Richard A Preston, Grigor Mamikonyan, Stephane DeGraff, James Chiou, Christopher J Kemper

Antimicrob Agents Chemother· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Renal Impairment Has Minimal Impact on Doravirine Pharmacokinetics.
Wendy Ankrom, Ka Lai Yee, Rosa I Sanchez, Adedayo Adedoyin, Li Fan, Richard A Preston

Antimicrob Agents Chemother· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment.
William L Marshall, Hwa-Ping Feng, Larissa Wenning, Graigory Garrett, Xiaobi Huang, Richard A Preston

Eur J Drug Metab Pharmacokinet· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry.
Shu Yang, Miao Xu, Emily M Lee, Kirill Gorshkov, Sergey A Shiryaev, Richard A Preston

Cell Discov· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Mild to Severe Hepatic Impairment on the Pharmacokinetics of Sonidegib: A Multicenter, Open-Label, Parallel-Group Study.
Yves Horsmans, Jocelyn Zhou, Mateva Liudmila, George Golor, Oren Shibolet, Richard A Preston

Clin Pharmacokinet· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects.
Matthew P Kosloski, Weihan Zhao, Thomas C Marbury, Richard A Preston, Michael G Collins

Antimicrob Agents Chemother· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment.
Caroline Dudkowski, Aziz Karim, Zhen Zhao, Alberto B Alonso, Dyal Garg, Richard A Preston

J Clin Pharmacol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies.
Tomohiro Kusawake, Donna Kowalski, Akitsugu Takada, Kota Kato, Masataka Katashima, Richard A Preston

Adv Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prehypertension is real and can be associated with target organ damage.
Barry J Materson, Manuel Garcia-Estrada, Stephane B Degraff, Richard A Preston

J Am Soc Hypertens· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.
Randall Hoover, Thomas C Marbury, Richard A Preston, Megan Quintas, Laura E Lawrence

J Clin Pharmacol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis